Tectonic Therapeutic (TECX) Other Non-Current Liabilities (2017)
Tectonic Therapeutic (TECX) reported Other Non-Current Liabilities of $371000.0 for Q4 2017.
Tectonic Therapeutic (TECX) Other Non-Current Liabilities (2017) Analysis & Trends
Tectonic Therapeutic (TECX) has 1 years of Other Non-Current Liabilities data on file, last reported at $371000.0 in Q4 2017.
- Other Non-Current Liabilities for Q4 2017 came in at $371000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2017 was $371000.0 (changed N/A YoY), and the FY2017 annual result was $371000.0, changed N/A from the prior year.
- Other Non-Current Liabilities held at $371000.0 in Q4 2017 per TECX's latest filing.
- Over five years, Other Non-Current Liabilities peaked at $371000.0 in Q4 2017 and troughed at $371000.0 in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Tectonic Therapeutic | 528.16 Mn | 291.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 371,000.00 |